Latest Insider Transactions at Sab Biotherapeutics, Inc. (SABS)
This section provides a real-time view of insider transactions for Sab Biotherapeutics, Inc. (SABS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SAB Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SAB Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2023
|
Eddie Joe Sullivan PRESIDENT |
BUY
Open market or private purchase
|
Direct |
1,740
+0.03%
|
$0
$0.88 P/Share
|
|
Nov 30
2023
|
Michael King CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$0
$0.9 P/Share
|
|
Nov 29
2023
|
Samuel J Reich CEO & EXECUTIVE CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
11,000
+4.78%
|
$0
$0.89 P/Share
|
|
Nov 24
2023
|
Helen K. Ellias |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,857,142
+50.0%
|
-
|
|
Nov 24
2023
|
Andrew Moin |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,584,571
+50.0%
|
-
|
|
Nov 24
2023
|
Sessa Capital (Master), L.P. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,584,571
+50.0%
|
-
|
|
Mar 14
2023
|
Alexandra Kropotova CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
275,000
+50.0%
|
-
|
|
Dec 07
2022
|
Jeffrey G Spragens |
BUY
Grant, award, or other acquisition
|
Direct |
82,987
+17.36%
|
$82,987
$1.21 P/Share
|
|
Dec 07
2022
|
David Charles Link |
BUY
Grant, award, or other acquisition
|
Direct |
41,493
+41.99%
|
$41,493
$1.21 P/Share
|
|
Dec 07
2022
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
82,987
+2.6%
|
$82,987
$1.21 P/Share
|
|
Sep 13
2022
|
Christine E Hamilton |
BUY
Open market or private purchase
|
Direct |
10,000
+0.2%
|
$0
$0.73 P/Share
|
|
Sep 07
2022
|
Eddie Joe Sullivan PRESIDENT |
BUY
Open market or private purchase
|
Direct |
14,000
+0.27%
|
$0
$0.74 P/Share
|
|
Jun 06
2022
|
Alexandra Kropotova CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
May 20
2022
|
Samuel J Reich CEO & EXECUTIVE CHAIRMAN |
BUY
Other acquisition or disposition
|
Direct |
207,001
+49.88%
|
-
|
|
May 20
2022
|
Samuel J Reich CEO & EXECUTIVE CHAIRMAN |
SELL
Other acquisition or disposition
|
Indirect |
2,500,127
-82.03%
|
-
|
|
May 20
2022
|
Jeffrey G Spragens |
BUY
Other acquisition or disposition
|
Direct |
299,002
+48.94%
|
-
|
|
Oct 26
2021
|
Russell P Beyer Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
278
-100.0%
|
$1,946
$7.9 P/Share
|
|
Oct 25
2021
|
Russell P Beyer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
129
+31.7%
|
$903
$7.78 P/Share
|
|
Oct 22
2021
|
David Charles Link |
BUY
Grant, award, or other acquisition
|
Indirect |
12,097
+50.0%
|
-
|
|
Oct 22
2021
|
David Charles Link |
BUY
Grant, award, or other acquisition
|
Direct |
15,820
+50.0%
|
-
|
|
Oct 22
2021
|
Frederick Finnegan Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,596
+50.0%
|
-
|
|
Oct 22
2021
|
Thomas Charles Luke Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,428
+50.0%
|
-
|
|
Oct 22
2021
|
Eddie Joe Sullivan PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
5,213,764
+50.0%
|
-
|
|
Oct 22
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
4,974,497
+50.0%
|
-
|
|
Oct 22
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
5,049,351
+50.0%
|
-
|
|
Oct 22
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
5,049,351
+50.0%
|
-
|
|
Oct 22
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
4,974,497
+50.0%
|
-
|
|
Oct 19
2021
|
Thomas Charles Luke Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
990
+50.0%
|
$9,900
$10.1 P/Share
|
|
Oct 18
2021
|
Russell P Beyer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,475
+50.0%
|
$24,750
$10.1 P/Share
|
|
Oct 14
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
5,092
+50.0%
|
$50,920
$10.1 P/Share
|
|
Oct 14
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
5,092
+50.0%
|
$50,920
$10.1 P/Share
|
|
Oct 14
2021
|
Samuel J Reich CEO & EXECUTIVE CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$10,000
$10.11 P/Share
|
|
Oct 13
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
20,800
+50.0%
|
$208,000
$10.1 P/Share
|
|
Oct 13
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
20,800
+50.0%
|
$208,000
$10.1 P/Share
|
|
Oct 13
2021
|
Ilan Katz Director |
BUY
Open market or private purchase
|
Direct |
500
+25.0%
|
$5,000
$10.11 P/Share
|
|
Oct 12
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
25,000
+50.0%
|
$250,000
$10.08 P/Share
|
|
Oct 12
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
$250,000
$10.09 P/Share
|
|
Oct 12
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
50,000
+50.0%
|
$500,000
$10.09 P/Share
|
|
Oct 07
2021
|
Eddie Joe Sullivan PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+50.0%
|
$28,000
$10.07 P/Share
|
|
Oct 01
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
2,695
+50.0%
|
$26,950
$10.1 P/Share
|
|
Oct 01
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
2,695
+50.0%
|
$26,950
$10.1 P/Share
|
|
Oct 01
2021
|
Ilan Katz Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$10,000
$10.09 P/Share
|
|
Oct 01
2021
|
Jeffrey G Spragens |
BUY
Open market or private purchase
|
Direct |
13,000
+50.0%
|
$130,000
$10.07 P/Share
|
|
Sep 29
2021
|
Russell P Beyer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
10
+40.0%
|
$100
$10.08 P/Share
|
|
Sep 28
2021
|
Russell P Beyer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
154
+50.0%
|
$1,540
$10.08 P/Share
|
|
Jan 14
2021
|
Big Cypress Holdings LLC CEO and CFO |
BUY
Open market or private purchase
|
Direct |
417,200
+12.04%
|
$4,172,000
$10.0 P/Share
|
|
Jan 14
2021
|
Ilan Katz Director |
BUY
Open market or private purchase
|
Indirect |
417,200
+12.04%
|
$4,172,000
$10.0 P/Share
|
|
Jan 14
2021
|
Samuel J Reich CEO & EXECUTIVE CHAIRMAN |
BUY
Open market or private purchase
|
Indirect |
417,200
+12.04%
|
$4,172,000
$10.0 P/Share
|